A twelve-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging, phase II study to assess the clinical efficacy of alosetron (GR68755) in male subjects with irritable bowel syndrome

✍ Scribed by EDWARDS1, E

• Book ID: 123156501
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 26 KB
• Volume: 96
• Category: Article
• ISSN: 0002-9270
• DOI: 10.1016/S0002-9270(01)03784-4